-+ 0.00%
-+ 0.00%
-+ 0.00%

Biocon Malaysia wins UK MHRA approval for Semglee insulin fill-finish unit

PUBT·09/25/2026 05:21:01
Biocon Malaysia wins UK MHRA approval for Semglee insulin fill-finish unit
  • Biocon Biologics won UK MHRA clearance for a new insulin fill-finish unit at its Malaysia manufacturing site.
  • The authorization covers Semglee (insulin glargine) drug product filling operations at the new line.
  • The facility previously secured EMA regulatory clearance for the same fill-finish line in July.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biocon Biologics Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: IQ95IVELRRW7G49Z) on September 25, 2026, and is solely responsible for the information contained therein.